摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trifluoromethanesulfonic acid 6-fluoronaphthalen-2-yl ester | 373380-86-0

中文名称
——
中文别名
——
英文名称
trifluoromethanesulfonic acid 6-fluoronaphthalen-2-yl ester
英文别名
6-Fluoro-2-naphthyl trifluoromethanesulfonate;(6-Fluoronaphthalen-2-yl) trifluoromethanesulfonate;(6-fluoronaphthalen-2-yl) trifluoromethanesulfonate
trifluoromethanesulfonic acid 6-fluoronaphthalen-2-yl ester化学式
CAS
373380-86-0
化学式
C11H6F4O3S
mdl
——
分子量
294.226
InChiKey
VFFVJPDOVURYPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.09
  • 拓扑面积:
    51.8
  • 氢给体数:
    0
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    trifluoromethanesulfonic acid 6-fluoronaphthalen-2-yl estersodium hydroxide 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 0.5h, 生成 5-Bromo-N-((E)-3-{5-chloro-2-[(6-fluoro-2-naphthyl)methyl]phenyl}-2-propenoyl)-2-methoxybenzenesulfonamide
    参考文献:
    名称:
    Structure–activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
    摘要:
    Potent and selective antagonists of the human EP3 receptor have been identified. The structure-activity relationship of the chemical series was conducted and we found several analogues displaying sub-nanomolar K-i values at the EP3 receptor and micromolar activities at the EP1, EP2 and EP4 receptors. The effect of added human serum albumin (HSA) on the binding affinity at the EP3 receptor was also investigated. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(01)00110-9
点击查看最新优质反应信息

文献信息

  • Pharmaceutical compounds
    申请人:——
    公开号:US20040122001A1
    公开(公告)日:2004-06-24
    This invention relates to compounds of formula (I) where R 1 to R 12 , —W—V—, —X—Y—, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals. 1
    这项发明涉及到式(I)的化合物,其中R1至R12,—W—V—,—X—Y—,m和n的值如权利要求1中定义的,它们的制备和用作药物。
  • PHARMACEUTICAL COMPOUNDS
    申请人:ELI LILLY AND COMPANY
    公开号:EP1345930A2
    公开(公告)日:2003-09-24
  • [EN] PHARMACEUTICAL COMPOUNDS<br/>[FR] COMPOSES PHARMACEUTIQUES
    申请人:LILLY CO ELI
    公开号:WO2002050067A2
    公开(公告)日:2002-06-27
    This invention relates to compounds of formula (I) where R?1 to R12¿, -W-V-, -X-Y-, m and n have the values defined in claim 1, their preparation and use as pharmaceuticals.
  • Structure–activity relationship of cinnamic acylsulfonamide analogues on the human EP3 prostanoid receptor
    作者:Hélène Juteau、Yves Gareau、Marc Labelle、Claudio F Sturino、Nicole Sawyer、Nathalie Tremblay、Sonia Lamontagne、Marie-Claude Carrière、Danielle Denis、Kathleen M Metters
    DOI:10.1016/s0968-0896(01)00110-9
    日期:2001.8
    Potent and selective antagonists of the human EP3 receptor have been identified. The structure-activity relationship of the chemical series was conducted and we found several analogues displaying sub-nanomolar K-i values at the EP3 receptor and micromolar activities at the EP1, EP2 and EP4 receptors. The effect of added human serum albumin (HSA) on the binding affinity at the EP3 receptor was also investigated. (C) 2001 Elsevier Science Ltd. All rights reserved.
查看更多